FY2023
Global Cancer Advancements in Immunotherapy Research
See how CRI is transforming the lives of cancer patients on a global scale.
Want to learn more?
We invite you to download the following educational resources.
Get the Infographic
Explore in-depth insights, at a glance.
Get the Impact Report
Access FY2023 highlights and accomplishments.
$515M
invested in CRI scientists worldwide since 1953
$28.7M
invested in research grants and fellowships in FY2023
12
new FDA approvals
01 / Impact
Fueling the Next Wave of Discovery
CRI funds scientists from around the world to advance new avenues of discovery, new technologies, and new ways to analyze and share data about our immune system and it’s power to outsmart cancer.
02 / Cancers
Redefining Immunotherapy Success
CRI scientists are accelerating discovery thanks to new technologies that marry data science, bioinformatics, and cancer immunology. To date, there are 4M patients eligible for immunotherapy treatments worldwide.
28
cancers now treatable with immunotherapy thanks to the work of CRI
Make your impact on cancer research
03 / people
Empowering the Best Scientists
CRI’s research is guided by our prestigious Scientific Advisory Council, led by 2018 Nobel Laureate James P. Allison, PhD. Our scientists are leading the charge to advance immunotherapy discovery and shaping the future of the field.
04 / Research
Recognizing Research Excellence
CRI-funded scientists had 300 publications of news-worthy research in top-tier peer-reviewed academic journals this year.
300
publications
Make your impact on cancer research
05 / Discovery
Unleashing Science with the Power of Data
CRI funded a clinical trial spearheaded by Dr. Valsamo “Elsa” Anagnostou, MD, PhD, from Johns Hopkins, investigating ctDNA technology’s potential. This method, through a blood draw, provides valuable insights into tumor genetics and activity. The trial showed that ctDNA analysis yielded faster, more accurate responses and enhanced predictions for long-term patient outcomes.
Our Mission
Save more lives by fueling the discovery and development of powerful immunotherapies for all cancers.
This year, CRI proudly celebrates funding 70 years of discovery in cancer immunotherapy. As a top-tier nonprofit that upholds fiscal integrity and transparency, CRI ensures every donation fuels impactful cancer immunotherapy research. Ranked among the top 5% of U.S. charities, we’re dedicated to saving lives worldwide.